| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 85509-2910-6 | 85509-2910 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260213 | N/A | ANDA | ANDA040489 | PHOENIX RX LLC | METHOCARBAMOL | 500 mg/1 | 60 TABLET in 1 BOTTLE (85509-2910-6) |
| 85509-2910-9 | 85509-2910 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260213 | N/A | ANDA | ANDA040489 | PHOENIX RX LLC | METHOCARBAMOL | 500 mg/1 | 90 TABLET in 1 BOTTLE (85509-2910-9) |
| 87063-135-01 | 87063-135 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260307 | N/A | ANDA | ANDA040489 | ASCLEMED USA INC. | METHOCARBAMOL | 500 mg/1 | 100 TABLET in 1 BOTTLE (87063-135-01) |
| 87063-135-30 | 87063-135 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260307 | N/A | ANDA | ANDA040489 | ASCLEMED USA INC. | METHOCARBAMOL | 500 mg/1 | 30 TABLET in 1 BOTTLE (87063-135-30) |
| 87063-135-60 | 87063-135 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260307 | N/A | ANDA | ANDA040489 | ASCLEMED USA INC. | METHOCARBAMOL | 500 mg/1 | 60 TABLET in 1 BOTTLE (87063-135-60) |
| 87063-135-90 | 87063-135 | HUMAN PRESCRIPTION DRUG | Methocarbamol | methocarbamol | TABLET | ORAL | 20260307 | N/A | ANDA | ANDA040489 | ASCLEMED USA INC. | METHOCARBAMOL | 500 mg/1 | 90 TABLET in 1 BOTTLE (87063-135-90) |